Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8633300
APP PUB NO 20080200651A1
SERIAL NO

11917772

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to method for selective reduction and derivatization of recombinantly prepared engineered proteins comprising at least one non-native cysteine, wherein the reduction reaction is conducted in the presence of a redox buffer or in the presence of a triarylphosphine reducing agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVO NORDISK HEALTHCARE A/GANDREASSTRASSE 15 CH-8050 ZURICH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ostergaard, Henrik Lyngby, DK 7 197
Petersen, Anders Klarskov Naerum, DK 32 173

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation